The genetic alterations in pancreatic cancer often include the mutation of an oncogene, KRAS, with deregulation/inactivation of several tumour suppressors, namely BRCA1/2, p53, CDKN2A and SMAD44. This evidence concerns the gene KRAS and familial pancreatic carcinoma.